Navigation Links
HIV No Barrier to Getting Liver Transplant, Study Finds
Date:5/17/2013

FRIDAY, May 17 (HealthDay News) -- Liver transplants to treat a common type of liver cancer are a viable option for people infected with HIV, according to new research.

The Italian study, published May 10 in the journal The Oncologist, found that the AIDS-causing virus doesn't affect survival rates and cancer recurrence after transplants among HIV patients with this particular type of liver cancer, called hepatocellular carcinoma (HCC). The study's authors noted, however, that HCC is more aggressive in people with HIV and it is becoming a major cause of death among these patients as antiretroviral treatment prolongs their lives.

"The key message of this study is that liver transplantation is a valid option for HCC treatment in HIV-infected patients," the study's authors wrote in a journal news release. "We suggest that HIV-infected patients must be offered the same liver transplant options for HCC treatment currently provided to HIV-uninfected subjects."

The study involved 30 HIV-positive patients and 125 patients not infected with HIV who received a liver transplant to treat HCC at three different hospitals in northern Italy between 2004 and 2009.

During a follow-up period of roughly 32 months, the researchers found a recurrence of HCC in 6.7 percent of the patients with HIV and 14.4 percent of the patients who were not HIV positive.

The study also revealed that survival was similar for all of the patients one year after surgery and three years post-surgery.

The researchers, led by Dr. Fabrizio Di Benedetto, associate professor of surgery at the University of Modena, said the HIV-positive patients were treated with antiretroviral therapy until they underwent the transplant. The therapy was not resumed until their liver function stabilized after surgery.

None of the HIV-positive patients developed AIDS during the post-surgery follow-up period. The study's authors suggested that this may be due to timely resumption of HIV therapy following the liver transplant.

New options in antiviral therapy for people with HIV could improve control of the HIV virus as well as outcomes following liver transplant for HCC, the researchers said.

Patients with HIV undergoing liver transplant for HCC would benefit most from a multidisciplinary approach to care, the study authors said, which would involve collaboration among oncologists, radiologists, gastroenterologists, liver surgeons and infectious disease specialists.

More information

The American Cancer Society provides more information on hepatocellular carcinoma.

-- Mary Elizabeth Dallas

SOURCE: The Oncologist, news release, May 10, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Nano-devices that cross blood-brain barrier open door to treatment of cerebral palsy
2. Study identifies barriers to breast health care in Pakistan
3. Nurse leader resistance perceived as a barrier to high-quality, evidence-based patient care
4. Language Barrier Hurts Elderly Asthma Patients
5. Medicare: Barrier to hospice increases hospitalization
6. Kicking the habit -- new research examines the barriers to quitting smoking for smokers with asthma
7. Meningitis A vaccine breaks barrier; first to gain approval to travel outside cold chain
8. Cultural, social factors identified as barriers to minority participation in stem cell donation
9. Personalized plans to address barriers to HIV drug adherence boost chances of successful therapy
10. Baby wash does not damage babys skin barrier function, study finds
11. Baylor University researchers study barriers, resources to physical activity in Texas towns
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
HIV No Barrier to Getting Liver Transplant, Study Finds
(Date:3/28/2017)... ... March 28, 2017 , ... ... by the American Association of Integrative Medicine and available for application on Saturday, ... the AutismOne 2017 Conference in Colorado Springs. , Ed Arranga, president of AutismOne, ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Lice Treatment Center® ... March 13-16, was a busy spot this year. Liz Solovay and Adrian Picheny, ... preventing outbreaks among camp communities during the upcoming 2017 camping season. “Lice infestations ...
(Date:3/28/2017)... ... March 28, 2017 , ... Oily skin is a common and unwelcomed occurrence in people ... has a lot to offer to the discussion of dealing with excess skin oil. “Oily ... are many home remedies that can help remove the oily shine while keeping the skin ...
(Date:3/28/2017)... ... ... adventure that reveals the mystery of Kevin’s purpose. “A Prophets Bones” is the creation of ... of him that he had neglected to do, but this was from God and there ... who would have felt themselves to be special and better than others due to the ...
(Date:3/27/2017)... , ... March 27, 2017 , ... ... for clear braces. People who want straight teeth without the extensive time commitment ... in Clearwater, FL, without acquiring a referral. A custom-designed series of virtually invisible ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... YORK , March 28, 2017 ... investors, attention to these four stocks: The Medicines ... Pacira Pharmaceuticals Inc. (NASDAQ: PCRX), and Supernus Pharmaceuticals ... operate in the Generic Drugs space which is ... drugs. The key growth drivers for the industry are ...
(Date:3/28/2017)... ROCKVILLE, Md. , March 28, 2017 /PRNewswire/ ... dedicated to innovative therapeutics addressing cancer and other ... at the American Association for Cancer Research annual ... April 3 is entitled "Evaluation of ENMD-2076 ... and the second poster to be presented ...
(Date:3/28/2017)... , March 28, 2017  Medeon Biodesign, Inc., ... company, is pleased to announce that the Company ... of Panther Orthopedics, Inc., a San ... fixation solutions for orthopedic extremity applications.  ... expand rapidly, primarily due to procedure volume growth, ...
Breaking Medicine Technology: